Figure 4

Effectiveness evaluation of the risk prediction model constructed by lncRNAs in the current study. (A) Kaplan–Meier survival analysis for the risk model based on clinical data in TCGA dataset; the blue and red lines represent the low- and high-risk groups, respectively. (B) Results of ROC analysis on the risk model based on TCGA dataset. (C) Kaplan–Meier survival analysis for the risk model based on clinical data in the E-TABM-36 dataset; the blue and red lines represent the low- and high-risk groups, respectively. (D) Results of ROC analysis of the risk model based on the E-TABM-36 dataset.